Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BPZE1 in Healthy Adult Volunteers
NCT02453048Phase 1Completed
- Sponsor
- Inserm
- Start
- Sep 2015
- Primary completion
- Mar 2017
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, randomised trial of BPZE1 in pertussis (4 arms), sponsored by Inserm. Primary endpoint: Adverse Events at 28 days. Started Sep 2015; status: completed.
02
Drugs
BPZE1
03
Conditions
pertussis
Beyond the preview
Go deeper on NCT02453048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02453048.